SGLT-2 Inhibitors Reduce Glaucoma Risk in Type 2 Diabetes Patients
New AAO 2023 data suggests drugs like dapagliflozin and empagliflozin may provide greater protection against glaucoma than GLP-1 agonists or DDP-4 inhibitors.
Source: hcplive.com
Dpp 4 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dpp 4. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dpp 4 Today - Breaking & Trending Today